M-Fluorobenzylguanidine

Summary

M-Fluorobenzylguanidine (CHEMBL111272) is a phase-3 clinical-stage small molecule.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Small molecule
• Chemistry: 167.18 Da · C8H10FN3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL111272
Name	M-Fluorobenzylguanidine
Type	Small molecule
Max phase	3
FDA approved	no
PubChem CID	14963573
Molecular formula	C8H10FN3
Molecular weight	167.18
InChIKey	HNPHEZIYSZIWHH-UHFFFAOYSA-N

SMILES: C1=CC(=CC(=C1)F)CN=C(N)N

IUPAC name: 2-[(3-fluorophenyl)methyl]guanidine

Parent form; salt/anhydrous children: CHEMBL4650354

Patent coverage: 11 distinct patent families (23 SureChEMBL compound mentions), from 2 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).